Skip to main content

Peer Review reports

From: Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis

Original Submission
24 Jan 2021 Submitted Original manuscript
25 Jan 2021 Author responded Author comments - Teerapat Yingchoncharoen
27 Jan 2021 Author responded Author comments - Teerapat Yingchoncharoen
Resubmission - Version 2
25 Jan 2021 Submitted Manuscript version 2
9 Feb 2021 Reviewed Reviewer Report
4 Apr 2021 Reviewed Reviewer Report
22 Apr 2021 Author responded Author comments - Teerapat Yingchoncharoen
Resubmission - Version 3
22 Apr 2021 Submitted Manuscript version 3
23 Apr 2021 Author responded Author comments - Teerapat Yingchoncharoen
Resubmission - Version 4
23 Apr 2021 Submitted Manuscript version 4
1 May 2021 Reviewed Reviewer Report
10 May 2021 Reviewed Reviewer Report
27 May 2021 Author responded Author comments - Teerapat Yingchoncharoen
Resubmission - Version 5
27 May 2021 Submitted Manuscript version 5
28 May 2021 Author responded Author comments - Teerapat Yingchoncharoen
Resubmission - Version 6
28 May 2021 Submitted Manuscript version 6
1 Jun 2021 Author responded Author comments - Teerapat Yingchoncharoen
Resubmission - Version 7
1 Jun 2021 Submitted Manuscript version 7
6 Jun 2021 Reviewed Reviewer Report
18 Jun 2021 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
26 Jun 2021 Editorially accepted
2 Jul 2021 Article published 10.1186/s12872-021-02145-9

You can find further information about peer review here.

Back to article page